Table 1.
Overview of recently completed, current and planned clinical trials aimed at prevention of type 1 diabetes.
| Recently completed | Trial to Reduce IDDM in the Genetically at Risk (TRIGR) |
| BABYDIET study in Germany | |
| Finnish Dietary Intervention Trial for the Prevention of Type 1 Diabetes (FINDIA) | |
| TrialNet Nutritional Intervention to Prevent (NIP) Type 1 diabetes study | |
| Type 1 Diabetes Prediction and Prevention (DIPP) study in Finland | |
| Pre-POINT (Primary Oral/Intranasal INsulin Trial) and Pre-POINT-early in Germany | |
| Diabetes Prevention Trial-Type 1 (DPT-1) | |
| TrialNet Oral Insulin study | |
| Australian Intranasal Insulin Trial-I (INIT I) | |
| Diabetes Prevention—Immune Tolerance (DIAPREV-IT) study | |
| European Nicotinamide Diabetes Intervention Trial | |
| Current | TrialNet Teplizumab (anti-CD3) trial |
| TrialNet Abatacept (CTLA4-Ig) trial | |
| The CoRD Study with autologous cord blood in Australia | |
| DIAPREV-IT2 study | |
| Australian Intranasal Insulin Trial-II (INIT II) | |
| Future | TrialNet Aldomet (methyldopa) study |
| TrialNet Hydroxychloriquine | |
| TrialNet Rituximab and Abatacept | |
| Fr1da Insulin Intervention in Germany | |
| Adjunctive therapies such as glucagon-like peptide-1 receptor agonists | |